Advertisement

Immundefizienz als Ursache für die Entstehung hämatologischer Neoplasien

  • Bettina Borisch
  • Paulette Mhawech
  • Marianne Tinguely
Chapter
Part of the Molekulare Medizin book series (MOLMED)

Zusammenfassung

Zwischen Viren und dem humanen Immunsystem besteht eine enge Abhängigkeit. Die Entwicklung beider Partner im Lauf der Evolution hat zu spezifischen Anpassungen des einen an den anderen geführt. Zum Beispiel weisen molekularbiologische Argumente darauf hin, dass Retroviren einen wichtigen Faktor in der Evolution des humanen Immunsystems darstellen (Bagasra u. Amjad 2000, Villareal 1997). Es ist somit nicht erstaunlich, dass virale Infektionen und Alterationen des Immunsystems für hämatologische Neoplasien prädisponieren, die selbst oft Erkrankungen des Immunsystems darstellen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Agnello V, Chung RT, Kaplan L (1992) Role of hepatitis C infection in type II cryoglobulinemia. N Engl J Med 327:1490–1495PubMedGoogle Scholar
  2. Allander T, Drakenberg K, Beyene A et al. (2000) Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81. J Gen Virol 81:2451–2459PubMedGoogle Scholar
  3. Allen RC, Armitage RJ, Conley ME et al. (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990–993PubMedGoogle Scholar
  4. Aruffo A, Farrington M, Hollenbaugh D et al. (1993) The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM-syndrome. Cell 72:291–300PubMedGoogle Scholar
  5. Ashwell J, Lu F, Vacchio M (2000) Glucocorticoids in T cell development and function. Ann Rev Immunol 18:309–345Google Scholar
  6. Aydin F, Bartholomew PM, Vinson DG (1998) Primary T-cell lymphoma of the brain in a patient at advanced stage of acquired immunodeficiency syndrome. Arch Pathol Lab Med 122:361–365PubMedGoogle Scholar
  7. Babcock GJ, Hochberg D, Thorley-Lawson DA (2000) The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon de differentiation stage of the infected B cell. Cell Immunity 13:497–506Google Scholar
  8. Baer B, Bankier A, Biggin MD et al. (1984) DNA sequence and expression of the B59–8 Epstein-Barr virus genome. Nature 310:207–211PubMedGoogle Scholar
  9. Bagasra O, Amjad M (2000) Protection against retroviruses are owing to a different form of immunity. Appl Immunohistochem Molecul Morphol 8:133–146Google Scholar
  10. Baki K, Gudat F, Meier V, Borisch B, Hurwitz N (1999) EBV-assoziierte Lymphoproliferationen bei alten Patienten ohne nachgewiesenen Immundefekt. Schweiz Med Wochenschr 129:1419–1432Google Scholar
  11. Baron B, Nucifora G, McCabe N, Espinosa R, LeBeau MM, McKeithan TN (1993) Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;11) in B cell lymphomas. Proc Natl Acad Sci USA 90:5262–5266PubMedGoogle Scholar
  12. Bastard C, Tilly H, Lenormand B et al. (1993) Translocations involving band 3q27 and Ig regions in non-Hodgkin’s lymphoma. Blood 79:2527–2531Google Scholar
  13. Beck JM (1998) Pleural disease in patients with acquired immune deficiency syndrome. Clin Chest Med 19:341–349PubMedGoogle Scholar
  14. Benkerrou M, Jais JP, Leblond V et al. (1998) Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. Blood 9:3137–3147Google Scholar
  15. Beral V, Peterman T, Berkelman R, Jaffe R (1991) AIDS-associated non-Hodgkin’s lymphoma. Lancet 333:805–809Google Scholar
  16. Beylot-Barry M, Vergier B, Masquelier B et al. (1999) The spectrum of cutaneous lymphomas in HIV infection. A study of 21 cases. Am J Surg Pathol 23:1208–1216PubMedGoogle Scholar
  17. Bodegain C, Wolf H, Modrow S, Stuber G, Jilg W (1995) Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J Virol 69:4872–4879Google Scholar
  18. Borisch B, Finke J, Hennig I et al. (1992) Distribution and localization of Epstein-Barr virus subtypes A and B in AIDS-related lymphomas and lymphatic tissue of HIV-positive patients. J Pathol 168:229–236PubMedGoogle Scholar
  19. Borisch B, Caioni M, Hurwitz N et al. (1993a) Epstein-Barr virus subtype distribution in angioimmunoblastic lymphadenopathy. Int J Cancer 55:748–752PubMedGoogle Scholar
  20. Borisch B, Hennig I, Laeng RH, Waelti ER, Kraft R, Laissue J (1993b) Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin’s lymphoma of the midline granuloma type. Blood 82:858–864PubMedGoogle Scholar
  21. Borisch B, Raphael M, Swerdlow SH, Jaffe ES (2001) Lymphoproliferative diseases associated with primary immune disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman W (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of the haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 257–259Google Scholar
  22. Borisch-Chappuis B, Nezelof C, Muller H, Muller-Hermelink HK (1990) Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients. Am J Pathol 136:751–758PubMedGoogle Scholar
  23. Boyle MJ, Swanson CE, Turner JJILT, Roberts J, Penny R, Cooper DA (1990) Definition of two distinct types of AIDS-associated non Hodgkin’s lymphoma. Br J Haematol 76:506–512PubMedGoogle Scholar
  24. Boyle MJ, Sewell WA, Sculley TB et al. (1991) Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin’s lymphoma. Blood 78:3004–3011PubMedGoogle Scholar
  25. Buckley RH (2000) Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 343:1313–1324PubMedGoogle Scholar
  26. Buckley RH, Schiff RI, Schiff SE et al. (1997) Human severe combined immunodeficiency: genetic, phenotypic, functional diversity in one hundred eight infants. J Pediatr 130:378–387PubMedGoogle Scholar
  27. Buskila D, Gladmann DD, Hannh W, Kahn HJ (1989) Primary malignant lymphoma of the spleen in systemic lupus erythematodes. J Rheumatol 19:993–996Google Scholar
  28. Camilieri-Broet S, Davi F, Feuillard J, Michiels JF, Brousset P (1997) AIDS-related primary brain lymphomas: histopathological and immunohistochemical study of 51 cases. Hum Pathol 28:367–374Google Scholar
  29. Canioni D, Jabado N, Maclntyre E, Patey N, Emile JF, Brousse N (2001) Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria. Histopathology 38:146–159PubMedGoogle Scholar
  30. Cannon M, Cesarman E (2000) Kaposi’s sarkoma-associated herpes virus acquired immunodeficiency syndrome-related malignancy. Semin Oncol 27:409–419PubMedGoogle Scholar
  31. Capello D, Vitolo U, Pasqualucci L et al. (2000) Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasias. Blood 95:651–659PubMedGoogle Scholar
  32. Carbone A (1997) The spectrum of AIDS-related lymphoproliferative disorders. Adv Clin Pathol 1:13–19Google Scholar
  33. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186–1191PubMedGoogle Scholar
  34. Cesarman E, Chadburn A, Liu YF, Migliazza A, Dalla-Favera R, Knowels D (1998) Bcl-6 gene mutations in post-transplantation lymphoproliferative disorders (PT-LPDs) predict response to therapy and clinical outcome. Blood 92:2294–2302PubMedGoogle Scholar
  35. Chan CH, Hadlock KG, Fung SKH, Levy S (2001) VH1–69 gene is preferentially used by hepatitis C virus-associated B-cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 97:1023–1026PubMedGoogle Scholar
  36. Chang Y, Cesarman E, Pessin MS et al. (1994) Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266:1865–1869PubMedGoogle Scholar
  37. Chow DC, Shazad HS, Eickhoff L, Soloway GN, Saul Z (1996) Primary esophageal lymphoma in AIDS presenting as a nonhealing esophageal ulcer. Am J Gastroenterol 91:602–603PubMedGoogle Scholar
  38. Cobeta-Garcia JC, Ruiz-Jimeno MT, Fontova-Garrofe R (1993) Non-Hodgkin’s lymphoma, rheumatoid arthritis and methotrexate. J Rheumatol 20:200–202PubMedGoogle Scholar
  39. Coffey AJ, Brooksbank RA, Brandau O et al. (1998) Host response to EBV infection in X-linked lymphoproliferative disease results form mutations in SH2 domain encoding gene. Nat Genet 20:129–135PubMedGoogle Scholar
  40. Davis CL, Harrison KL, McVicar JP, Forg PJ, Bronner MP, Marsch CL (1995) Antiviral prophylaxis and the Epstein-Barr virus-related post-transplant lymphoproliferative disorder. Clin Transplant 9:53–59PubMedGoogle Scholar
  41. Davi F, Delecluse HJ, Giet P et al. (1998) Burkitt lymphoma in AIDS: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin’s lymphomas. J Clin Oncol 16:3788–3795PubMedGoogle Scholar
  42. Deacon EM, Pallesen G, Niedobitek G et al. (1993) Epstein-Barr virus and Hodgkin’s disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 177:339–349PubMedGoogle Scholar
  43. Dean M, Jacobson LP, McFarlane G et al. (1999) Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-D32 mutation. Cancer Res 59:3561–3564PubMedGoogle Scholar
  44. Delecluse HJ, Anagnostopoulos I, Dallenbach F et al. (1997) Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89:1413–1420PubMedGoogle Scholar
  45. De Re V, De Vita S, Marzotto A et al. (2000) Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin’s lymphomas suggested that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 96:3578–3584PubMedGoogle Scholar
  46. Derry JMJ, Ochs HD, Francke U (1994) Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78:635–644PubMedGoogle Scholar
  47. De Vita S, Sansonno D, Dolcetti R et al. (1995) Hepatitis C virus within malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 86:1887–1892PubMedGoogle Scholar
  48. De Vita S, Zagonel V, Russo A et al. (1998) Hepatitis C virus, non-Hodgkin’s lymphomas and hepatocellular carcinoma. Br J Cancer 77:2032–2035PubMedGoogle Scholar
  49. De Vita S, De Re V, Sansonno D et al. (2000) Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with auto-immune disease and in chronic gastritis. Hepatology 31:182–189PubMedGoogle Scholar
  50. Diebold J, Raphael M, Prévot S, Audoin J (1997) Lymphomas associated with HIV infection, vol 30: Lymphomas. Imperial Cancer Research Fund, LondonGoogle Scholar
  51. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, Saint Basile G de (1993) CD40 ligand mutations in X-linked immunodeficiency with hyper Ig-M. Nature 361:541–543Google Scholar
  52. Dykstra ML, Longnecker R, Pierce SK (2001) Epstein-Barr virus coopts lipd rafts to block the signaling and antigen transport functions of the BCR. Immunity 14:57–67PubMedGoogle Scholar
  53. Ellmann MH, Hurwitz H, Thomas C (1991) Lymphoma development in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18:1741–1743Google Scholar
  54. Embil JM, Halliday WC, Nath A (1997) Primary cerebellar T-cell lymphoma with acquired immunodeficiency syndrome. J Neurol Virol 3:229–232Google Scholar
  55. Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphopblasts from Burkitt’s lymphoma. Lancet 1:702–703PubMedGoogle Scholar
  56. Facchetti F, Blanzuoli L, Ungari M, Alebardi O, Vermi W (1998) Lymph node pathology in primary combined immunodeficiency diseases. Springer Semin Immunopathol 19:459–478PubMedGoogle Scholar
  57. Faure I, Viallard JF, Mercie P, Bonnefoie M, Pellegrin JL, Leng B (1999) Multiple myeloma in two HIV-infected patients. AIDS 10:1797–1799Google Scholar
  58. Ferri C, Marzo F, Longobardo G et al. (1993) Interferon-alpha in mixed cryoglobulinemia patients: a randomized, cross over-controlled trial. Blood 81:1132–1136PubMedGoogle Scholar
  59. Fiorina A, Atac C (1997) Paraproteinemia, plasmacytoma, myeloma and HIV infection. Leukemia 11:2150–2156Google Scholar
  60. Fishleder A, Tubbs R, Hesse B, Levine H (1987) Uniform detection of immunoglobulin gene rearrangement in benign lymphoepithelial lesions. N Engl J Med 316:1118–1121PubMedGoogle Scholar
  61. Frizzera G (1987) The clinicopathological expressions of Epstein-Barr virus infection in lymphoid tissues. Virchows Arch 53:1–12Google Scholar
  62. Frizzera G, Hanto DW, Gajl-Peczalska KJ (1981) Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41:4262–4279PubMedGoogle Scholar
  63. Gilbertson EO, Hunt SJ, Spellman NC (1996) Cutaneous T-cell lymphoma of the eyelid in a patient with acquired immunodeficiency syndrome. Cutis 57:437–440Google Scholar
  64. Ginaldi L, Martini M de, d’Ostilio A et al. (1999) The immune system in the elderly. Immunol Res 20:101–108PubMedGoogle Scholar
  65. Glanzmann E, Riniker P (1950) Essentielle Lymphocytose: ein neues Krankheitsbild aus der Säuglingspathologie. Ann Pediatr 175:1–32Google Scholar
  66. Globerson A-J (1995) T lymphocytes and aging. Int Arch Allergy Immunol 107:491–497PubMedGoogle Scholar
  67. Globerson A, Effros RB (2000) Ageing lymphocytes in the aged. Immunol Today 21:515–520PubMedGoogle Scholar
  68. Goedert JJ (2000) The epidemiology of acquired immunodeficiency syndrome. Semin Oncol 27:390–401PubMedGoogle Scholar
  69. Goodnow CC, Cyster JG, Hartley SB et al. (1995) Self-tolerance checkpoints in B lymphocyte development. Adv Immunol 59:279–368PubMedGoogle Scholar
  70. Gorochov G, Debré P, Leblond V, Sadat-Sowti B, Sigaux F, Autran B (1994) Oligoclonal expansion of CD8+CD57+T-cells with restricted T-cell receptor B-chain variability after bone marrow transplantation. Blood 83:587–595PubMedGoogle Scholar
  71. Grasser FA, Murray PG, Kremmer E et al. (1994) Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin’s disease. Blood 56:3792–3798Google Scholar
  72. Greenstein A, Genuso R, Sachar DB et al. (1985) Extraintestinal cancers in inflammatory bowel disease. Cancer 56:2913–2921Google Scholar
  73. Grierson HL, Skare J, Hawk J, Pauza M, Purtilo DT (1991) Immunoglobulin class and subclass deficiencies prior to Epstein-Batt virus infection in males with X-linked lymphoproliferative disease. Am J Med Genet 40:294–297PubMedGoogle Scholar
  74. Grulich AE (1999) AIDS-associated non-Hodgkin’s lymphoma in the era of highly active retroviral therapy. J Acquir Immune Defic Syndr 21:27–30Google Scholar
  75. Guilbert B, Dighiero G, Avrameas S (1982) Naturally occurring antibodies against nine common antigens in normal humans. I. Detection, isolation and characterization. J Immunol 128:2779–2787PubMedGoogle Scholar
  76. Gulley ML, Raphael M, Lutz CT, Ross DW, Raab-Taub N (1992) Epstein-Barr virus integration in human lymphomas and lymphoid cell lines. Cancer 70:185–191PubMedGoogle Scholar
  77. Hakulinen T, Tsomaki H, Knekt T (1985) Rheumatoid arthritis and cancer studies based on natiowide registries in Finland. Am F Med 78:29–32Google Scholar
  78. Hamilton-Dutoit SJ, Raphael M, Audoin F et al. (1993) In situ demonstration of Epstein-Barr virus small RNAs (EBER1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 82:619–624PubMedGoogle Scholar
  79. Han S, Hathcock K, Zheng B, Kepler TB, Hodes R, Kelsoe G (1995) Cellular interaction in germinal centers. Roles of CD40 ligand and B7–2 in established germinal centers. J Immunol 155:556–567PubMedGoogle Scholar
  80. Hanto DW, Frizzera G, Gajl-Peczalska KJ et al. (1982) Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 306:913–918PubMedGoogle Scholar
  81. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL (1985) Epstein-Barr virus, immunodeficiency and B-cell lymphoproliferation. Transplantation 39:461–472PubMedGoogle Scholar
  82. Harris NL, Jaffe ES, Stein H et al. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392PubMedGoogle Scholar
  83. Hartmann H, Schott P, Polzien F (1995) Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates. Z Gastroenter 33:643–650Google Scholar
  84. Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg S (1992) Increased incidence of Hodgkin’s disease in homosexual men with HIV infection. Ann Intern Med 117:309–311PubMedGoogle Scholar
  85. Holladay AO, Siegel RJ, Schwartz DA (1992) Cardiac malignant lymphoma in acquired immunodeficiency syndrome. Cancer 70:2203–2207PubMedGoogle Scholar
  86. Hsi ED, Greenson JK, Singleton TP, Siddiqui J, Schnitzer B, Ross CW (1996) Detection of immunoglobulin heavy chain gene rearrangement by polymerase chain reaction in chronic aggressive gastritis associated with Helicobacter pylori. Hum Pathol 27:290–296PubMedGoogle Scholar
  87. Hyjek E, Isaacson PG (1988) Primary B-cell lymphoma of the thyroid and its relationship to Hashimoto thyroiditis. Hum Pathol 19:1315–1326PubMedGoogle Scholar
  88. Hyjek E, Schmith WJ, Isaacson PG (1988) Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum Pathol 19:766–776PubMedGoogle Scholar
  89. Ioachim HL, Dorsett B, Cronin W, Maya M, Wahl S (1991) Acquired immunodeficiency syndrome-associated lymphomas: clinical, pathologic, immunologic, viral characteristics of 111 cases. Hum Pathol 22:659–673PubMedGoogle Scholar
  90. Isaacson PG (1994) Gastrointestinal lymphoma. Hum Pathol 25:1020–1029PubMedGoogle Scholar
  91. Isaacson PG, Spencer J (1987) Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 11:445–462PubMedGoogle Scholar
  92. Izumi KM, Kaye KM, Kieff ED (1997) The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc Natl Acad Sci USA 94:1447–1452PubMedGoogle Scholar
  93. Jacard A, Emile JF, Metivier F, Clauvel JP, d’Agay MF (1997) Epstein-Barr virus associated Hodgkin’s disease following renal transplantation. Am J Hematol 46:256–257Google Scholar
  94. Jacob J, Kelsoe G, Rajewski R, Weiss U (1991) Mutational generation of antibody mutants in germinal centers. Nature 354:389–392PubMedGoogle Scholar
  95. Jaffe ES (2001) World Health Organization classification of tumours-pathology and genetics of tumours of haemopoietic and lymphoid tissues. Oxford University Press, Oxford New YorkGoogle Scholar
  96. Jhala DN, Medeiros JL, Lopez-Terrada D, Jhala NC, Krishnan B, Shabab I (2000) Neutrophil-rich anaplastic large cell lymphoma of T-cell lineage. A report of two cases arising in HIV-positive patients. Am J Clin Pathol 114:478–482PubMedGoogle Scholar
  97. Jones WF, Scikh Y, McClave SA (1997) AIDS-related non-Hodgkin’s lymphoma of the pancreas. Am J Gastroenterol 92:335–338PubMedGoogle Scholar
  98. Jordan RCK, Chong L, Dipierdomenico S, Satira F, Main JHP (1998) Oral lymphoma in human immunodeficiency virus infection: a report of six cases and review of the literature. Otolaryngol Head Neck Surg 119:672–677PubMedGoogle Scholar
  99. Kamel OW (1997) Iatrogenic lymphoproliferative disorders in nontransplantation settings. Semin Diagn Pathol 14:27–34PubMedGoogle Scholar
  100. Kamel O, Rijn M van de, Weiss LM et al. (1993) Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328:1317–1321PubMedGoogle Scholar
  101. Kaplan DS, Abrams DI, Feigl E et al. (1989) AIDS-associated non-Hodgkin’s lymphoma in San Francisco. JAMA 261:719–724PubMedGoogle Scholar
  102. Karcher DS, Dawkins F, Garrett CT (1992) Body cavity-based non-Hodgkin’s lymphoma (NHL) in HIV-infected patients: B-cell lymphoma with unusual clinical immunophenotypic, genetic features. Lab Invest 92:80aGoogle Scholar
  103. Kemnitz J, Cremer J, Gebel M, Uysal A, Haverich A, Georgii A (1990) T-cell lymphoma after heart lung transplantation. Am J Clin Pathol 94:95–101PubMedGoogle Scholar
  104. Kenagy DN, Schlesinger Y, Weck K, Ritter JH, Gaudreault-Keener MM, Storch GA (1995) Epstein-Barr virus DNA in peripheral blood leucocytes of patients with posttransplant lymphoproliferative disease. Transplantation 60:547–554PubMedGoogle Scholar
  105. Khanim F, Yao QY, Niedobitek G, Sihota S, Rickinson AB, Young LS (1996) Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 88:3491–3501PubMedGoogle Scholar
  106. Khanna R, Burrows SR, Kurilla MG et al. (1992) Localization of Epstein-barr virus cytotoxic T-cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med 176:157–168Google Scholar
  107. Kieff E (1996) Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM (eds) Virology. Raven Press, New YorkGoogle Scholar
  108. Kieserman SP, Finn DG (1995) Non-Hodgkin’s lymphoma of the external auditory canal in an HIV-positive patient. J Laryngol Otol 109:751–754PubMedGoogle Scholar
  109. Kingma DW, Mueller BU, Frekko K et al. (1999) Low-grade monoclonal Epstein-Barr virus-associated lymphoproliferative disorder of the brain presenting as human immunodeficiency virus-associated encephalopathy in a child with acquired immunodeficiency syndrome. Arch Pathol Lab Med 123:83–87PubMedGoogle Scholar
  110. Knight JG, Iaing P, Adams DD (1986) Autoantibodies to acetylcholine receptor in myasthenia gravis: light chains. Neurology 36:1531–1536PubMedGoogle Scholar
  111. Knowles DM, Chamaluk GA, Subar M et al. (1988) Lymphoid neoplasia associated with the acquired immune deficiency syndrome (AIDS). Ann Intern Med 108:744–753PubMedGoogle Scholar
  112. Korthauer U, Graf D, Mages HW et al. (1993) Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539–541PubMedGoogle Scholar
  113. Kurth J, Spieker T, Wustrow J et al. (2000) Tracing EBV-infected B-cells in infectious mononucleosis: viral strategies for spreading in the B-cell compartment and establishment of latent infection. Immunity 13:485–495PubMedGoogle Scholar
  114. LaCivita L, Zignego AL, Monti M, Longobardi G, Pasero G, Ferri C (1995) Mixed cryoglobulinemia as a possible preneoplastic disorder. Arthritis Rheum 38:1859–1860PubMedGoogle Scholar
  115. Lallemand F, Fritsch L, Cywiner-Golenzer C, Rozenbaum W (1998) Multiple myeloma in an HIV-positive man presenting with primary cutaneous plasmacytomas and spinal cord compression. J Am Acad Dermatol 39:506–508PubMedGoogle Scholar
  116. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS (1983) Abnormalities of B cell activation and immunoregulation in patients with AIDS. N Engl J Med 309:453–458PubMedGoogle Scholar
  117. Leblond V, Davi F, Charlotte F et al. (1998) Post-transplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 16:2052–2059PubMedGoogle Scholar
  118. Ledergerber B, Telenti A, Eifer M (1999) Risk of HIV-related Kaposi’s sarcoma and non Hodgkin lymphoma with potent antiretroviral therapy: prospective cohort study. BMJ 319:23–24PubMedGoogle Scholar
  119. Legendre C, Kreis H (1992) Effect of immunosuppression on the incidence of lymphoma formation. Clin Transplant S6:220–221Google Scholar
  120. Lekstrom-Himes JA, Gallin JI (2000) Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med 343:1703–1714PubMedGoogle Scholar
  121. Leonie G, Mele L, Pulsoni A, Equitani F, Pagano L (1999) The incidence of secondary leukemias. Haematologica 84:937–945Google Scholar
  122. Levine AM (1993) AIDS-related malignacies: the emerging epidemic. J Natl Cancer Inst 85:1382–1397PubMedGoogle Scholar
  123. Levine AM (2000) Acquired immunodeficiency syndrome-related lymphoma: clinical aspects. Semin Oncol 27:442–453PubMedGoogle Scholar
  124. Levine AM, Bernstein L, Sullivan-Halley J, Shibata D, Mahterian SB, Nathwani BN (1995) Role of zivudine in antiretroviral therapy in the pathogenesis of acquired immunodeficiency syndrome-related lymphoma. Blood 86:4612–4616PubMedGoogle Scholar
  125. Levitskaya J, Coram M, Levitsky Vet al. (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685–688PubMedGoogle Scholar
  126. Lo Coco F, Ye BH, Lista F et al. (1994) Rearrangements of the BCL-6 gene in diffuse large cell non-Hodgkin’s lymphoma. Blood 83:1757–1759PubMedGoogle Scholar
  127. Lunel F, Cacoub P (1999) Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection. J Hepatol 31:210–216PubMedGoogle Scholar
  128. Lutz HU, Wipf G (1982) Naturally-occurring auto-antibodies to skeletal proteins from human red blood cells. J Immunol 128:1695–1701PubMedGoogle Scholar
  129. Matthews GV, Bower M, Mandalia S, Powles T, Nelson MR, Gazzard BG (2000) Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active anti-retroviral therapy. Blood 96:2730–2734PubMedGoogle Scholar
  130. Maurer R, Taylor CR, Terry R, Lukes RJ (1979) Non-Hodgkin’s lymphoma of the thyroid. A clinicopathologic review of 29 cases applying the Lukes-Collins classification and an immunoperoxidase method. Virchows Arch 383:293–317Google Scholar
  131. McClain KL, Leach CT, Jenson HB et al. (2000) Molecular and virologie characteristics of lymphoid malignancies in children with AIDS. J Acquir Immun Defic Syndr 23:152–159Google Scholar
  132. McDermott MRJB (1979) Evidence for a common mucosal immune system: migration of B immunoblasts into intestinal, respiratory and genital tissue. J Immunol 122:1892–1898PubMedGoogle Scholar
  133. McMahon EME, Glass JD, Hayward SD et al. (1991) Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 338:969–973Google Scholar
  134. Misiani R, Bellavita P, Fenili D et al. (1994) Interferon-α-2a therapy in cryoglobulinemia associated hepatitis C virus. N Engl J Med 330:751–756PubMedGoogle Scholar
  135. Monteverde A, Balare M, Bertoncelli MC et al. (1995) Lymphoproliferation in type II mixed cryoglobulinemia. Clin Exp Rheumatol 13:S141–147PubMedGoogle Scholar
  136. Morris CR, Morris AJ (1993) Localized lymphoma in a patient with rheumatoid arthritis treated with parenteral methotrexate. J Rheumatol 20:2172–2173PubMedGoogle Scholar
  137. Munoz A, Schrager LK, Bacellar H et al. (1993) Trends in the incidence of outcomes defining acquired immune deficiency syndrome (AIDS) in the multicenter AIDS cohort study: 1985–1991. Am J Epidemiol 137:423–428PubMedGoogle Scholar
  138. Murray PG, Swinnen LJ, Constantinidou CM et al. (1996) BCL-2 but not its Epstein-barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders. Blood 87:706–711PubMedGoogle Scholar
  139. Nalesnik MA (1996) Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. Semin Thorac Cardiovasc Surg 8:139–148PubMedGoogle Scholar
  140. Nalesnik MA, Jaffe R, Starzl E (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133:173–192PubMedGoogle Scholar
  141. Nalesnik MA, Randhawa P, Demetris AJ, Casavilla A, Fung JJ, Locker J (1993) Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer 72:2568–2573PubMedGoogle Scholar
  142. Nelson BP, Nalesnik MA, Bahler DW, Locker J, Fung JJ, Swerdlow SH (2000) Epstein-Barr virus-negative posttransplant lymphoproliferative disorders. A distinct entity? Am J Surg Pathol 24:375–385PubMedGoogle Scholar
  143. Nichols KE, Harkin DP, Levitz S et al. (1998) Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 95:13.765–13.770Google Scholar
  144. Niedobitek G, Kremmer E, Herbst H et al. (1997) Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin’s disease and infectious mononucleosis. Blood 90:1664–1672PubMedGoogle Scholar
  145. Nogues X, Supervis A, Knobel H, Lopez-Colomes JL, Serrano S, Abella E (1996) Multiple myeloma and AIDS. Am J Hematol 53:210–211PubMedGoogle Scholar
  146. Nosari A, Cantoni S, Oreste P et al. (1996) Anaplastic large cell (CD30/Ki-1+) lymphoma in HIV+ patients: clinical and pathological findings in a group of ten patients. Br J Haematol 95:508–512PubMedGoogle Scholar
  147. Obermayer-Straub P, Manns MP (2001) Hepatitis C and D, retroviruses and autoimmune manifestations. J Autoimmun 16:275–285PubMedGoogle Scholar
  148. Ochs HD, Smith CIE, Puck JM (1999) Primary immunodeficiency diseases: a molecular and genetic approach. Oxford University Press, Oxford New YorkGoogle Scholar
  149. Oudejans JJ, Jiwa M, Van den Brule AJC et al. (1995) Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. Am J Pathol 147:923–933PubMedGoogle Scholar
  150. Pallesen G, Hamilton-Dutoit S J, Rowe M et al. (1991) Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin’s lymphoma cells. J Pathol 165:289–299PubMedGoogle Scholar
  151. Pantaleo G, Graziosi C, Butini L et al. (1991) Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci USA 88:9838–9842PubMedGoogle Scholar
  152. Parham P (2000) The immune system. Garland Publishing Co, New York LondonGoogle Scholar
  153. Pawlotsky JM, Ben Yahia M, André C et al. (1994) Immunological disorders in C virus chronic active hepatitis: a prospective case control study. Hepatology 19:841–848PubMedGoogle Scholar
  154. Pearce N, Porta M (1986) Association of non-Hodgkin’s lymphoma with rheumatoid arthritis. Am J Med 81:747–748PubMedGoogle Scholar
  155. Peeva E, Davidson A, Keiser HD (1999) Synovial non-Hodgkin’s lymphoma in a human immunodeficiency virus infected patient. J Rheumatol 26:696–698PubMedGoogle Scholar
  156. Pelicci PG, Knowles DM, Arlin ZA et al. (1986) Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immunedeficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med 164:2049–2060PubMedGoogle Scholar
  157. Penn I (1978) Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 83:492–502PubMedGoogle Scholar
  158. Penn I (1983) Lymphomas complicating organ transplantation. Transplant Proc 15:2790–2797Google Scholar
  159. Penn I (1992) Immunosuppression: a contributory factor in lymphoma formation? Clin Transplant 6:214–219Google Scholar
  160. Perl A, Gorevic PD, Ryan DH, Condemi JJ, Ruszkowski RJ, Abraham GN (1989) Clonal B-cell expansions in patients with essential mixed cryoglobulinemia. Clin Exp Immunol 76:54–60PubMedGoogle Scholar
  161. Pluda JM, Venzon DJ, Tosato G et al. (1993) Parameters affecting the development of non-Hodgkin’s lymphoma in patients with severe human deficiency virus infection receiving anti-retroviral therapy. J Clin Oncol 11:1099–1107PubMedGoogle Scholar
  162. Podbielski FJ, Pearsall GF, Nelson DG, Unti JA, Connolly MM (1997) Lymphoma of the extra-hepatic biliary ducts in acquired immunodeficiency syndrome. Am Surg 63:807–810PubMedGoogle Scholar
  163. Pomilla PV, Morris AB, Jaworek A (1995) Sino-nasal non Hodgkin’s lymphoma in patients infected with human immunodeficiency virus: report of three cases and review. Clin Infect Dis 21:137–149PubMedGoogle Scholar
  164. Pozzato G, Mazzaro C, Crovatto M et al. (1994) Low grade malignant lymphoma, hepatitis C virus infection, mixed cryoglobulinemia. Blood 84:3047–3053PubMedGoogle Scholar
  165. Purtilo DT (1981) Immune deficincy predisposing to Epstein-Barr virus induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model. Adv Cancer Res 34:279–312PubMedGoogle Scholar
  166. Raab-Traub N, Flynn K (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883–889PubMedGoogle Scholar
  167. Rabkin CS, Yang Q, Goedert JJ, Nguyen G, Mitsuya H, Sci S (1999) Chemokine and chemokine receptor gene variant s and risk of non-Hodgkin’s lymphoma in human immunodeficiency virus-1 infected individuals. Blood 93:1838–1842PubMedGoogle Scholar
  168. Raphael MM, Gentilhomme O, Tuillez M, Byron PA, Diebold J (1991) Histopathologic features of high-grade non-Hodgkin’s lymphomas in acquired immunodeficiency syndrome. Arch Pathol Lab Med 115:15–20PubMedGoogle Scholar
  169. Raphael MM, Audouin J, Lamine M et al. (1994) Immunophenotypic and genotypic analysis of acquired immunodeficiency-relatd non-Hoddkin’s lymphomas. Correlation with histologic features in 36 cases. French study group for HIV-associated tumors. Am J Clin Pathol 101:773–782PubMedGoogle Scholar
  170. Raphael MM, Borisch B, Jaffe ES (2001) Lymphomas associated with infection by the human immune deficiency virus (HIV). In: Jaffe ES, Harris NL, Stein H, Vardiman W (eds) Pathology & Genetics. Tumours of the haematopoietic and lymphoid tissues. IARC Press, LyonGoogle Scholar
  171. Reyes J, Tzakis A, Green M (1991) Post-transplant lymphoproliferative disorders occurring under primary FK506 immunosuppression. Transplant Proc 23:3044–3046PubMedGoogle Scholar
  172. Rheumatology ACo, Guidelines AhCoC (1996) Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 39:713–722Google Scholar
  173. Riddler SA, Breining MC, McKnight JLC (1994) Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant-lymphoproliferative disease in solid-organ transplant recipients. Blood 84:972–984PubMedGoogle Scholar
  174. Rooney CM, Smith CA, Ng CY et al. (1995) Use of genemodified virus-specific T-lymphocytes to control Epstein-Barr virus related lymphoproliferation. Lancet 345:9–13PubMedGoogle Scholar
  175. Roos J, Hennig I, Schwaller J et al. (2001) Expression of TCL1 in hematologic disorders. Pathobiology 69:59–66PubMedGoogle Scholar
  176. Rosen FS (1997) Primary immunodeficiency diseases. Report of WHO scientific group. Clin Exp Immunol 109 [Suppl 1]:1–28Google Scholar
  177. Ross CW, Schnitzer B, Sheldon S, Braun DK, Hanson CA (1994) Gamma/delta T-cell post-transplantation lymphoproliferative disorder primarily in the spleen. Am J Clin Pathol 102:310–315PubMedGoogle Scholar
  178. Rossi G, Donisi A, Casari S, Re A, Cadeo G, Carosi G (1999) The international prognostic index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-hodgkin’s lymphoma. Cancer 86:2391–2397PubMedGoogle Scholar
  179. Ryon JJ, Hayward SD, MacMahon EM et al. (1993) In situ detection of lytic Epstein-Barr virus infection: expression of the No1 early gene and vIL10 late gene in clinical specimens. J Infect Dis 168:345–351PubMedGoogle Scholar
  180. Said JW, Rettig MR, Heppner K et al. (1997) Localization of Kaposi’s sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 90:4278–4282PubMedGoogle Scholar
  181. Saloum E, Cooper DL, Gowe G (1996) Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatoid diseases. J Clin Oncol 14:1943–1949Google Scholar
  182. Santana V, Rose VR (1992) Neoplastic lymphoproliferation in autoimmune disease: an updated review. Clin Immunol Immunpathol 63:205–213Google Scholar
  183. Sato H, Takimoto T, Tanaka S, Tanaka J, Raab-Traub N (1990) Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines. J Virol 64:5295–5300PubMedGoogle Scholar
  184. Savoie A, Perpete C, Carpentier L, Joncas J, Alfieri C (1994) Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant recipients and risk of lymphoproliferative disease. Blood 83:2715–2722PubMedGoogle Scholar
  185. Sayos J, Wu C, Morra M et al. (1998) The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395:462–469PubMedGoogle Scholar
  186. Schmid U, Helbron D, Lennert K (1982) Development of malignant lymphoma in myoepithelial sialadenitis (Sjogren’s syndrome). Virchows Arch 395:11–43Google Scholar
  187. Schmidt W, Anagnostopoulos I, Scherübl H (2000) V virostatic therapy for advanced lymphoproliferation associated with the Epstein-Barr virus in an HIV-infected patient. N Engl J Med 342:440–441PubMedGoogle Scholar
  188. Schnittman S, Lane H, Higgins S, Folks T, Fauci A (1986) Direct polyclonal activation of human B lymphocytes by the human immunodeficiency sydrome virus. Science 233:1084–1086PubMedGoogle Scholar
  189. Schroeder HW, Dighiero G (1994) Clues to pathogenesis of CLL through analysis of B cell CLL antibody repertoires. Immunol Today 15:288–294PubMedGoogle Scholar
  190. Shiroky JB, Frost A, Skelton JD, Haegert DG, Newkirk MM, Neville C (1991) Complications of immunosuppression associated with weekly low dose methotrexat. J Rheumatol 18:1172–1175PubMedGoogle Scholar
  191. Simo R, Hartley C, Malik T, Wilson G, Taylor PH, Mandai BK (1998) Primary non-Hodgkin’s lymphoma of the larynx in an AIDS patient. J Laryngol Otol 112:77–80PubMedGoogle Scholar
  192. Simon M, Borisch B, Heymer B (1996) Epstein-Barr-virus associated lymphoproliferative syndrome in severe combined immunodeficiency: establishment of a lymphoblastoid cell line as an in vitro model for biological and therapeutic studies. Acta Haematol 96:170–177PubMedGoogle Scholar
  193. Sixbey J, Shirley P, Chesney P, Buntin D, Resnick L (1989) Detection of a second widespread strain of Epstein-Barr virus. Lancet 2:761–765PubMedGoogle Scholar
  194. Soulier J, Grollet L, Oksenhendler E et al. (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86:1276–1280PubMedGoogle Scholar
  195. Spencer J, MacDonald TT, Diss TC, Walker-Smith JA, Ciclitira PJ, Issacson PG (1989) Changes in intraepithelial lymphocyte subpopulations in coeliac disease and enteropathy associated T cell lymphoma. Gut 30:339–346PubMedGoogle Scholar
  196. Starzl TE, Nalesnik MA, Porter KA et al. (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 17:583–587Google Scholar
  197. Stevens SJC, Verschuuren EAM, Pronk I et al. (2001) Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high risk patients. Blood 97:1165–1171PubMedGoogle Scholar
  198. Sullivan JL, Woda BA (1989) X-linked lymphoproliferative syndrome. Immunodefic Rev 1:325–347PubMedGoogle Scholar
  199. Swinnen LJ (2000) Diagnosis and treatment of transplant-related lymphoma. Ann Oncol [Suppl 1] 11:45–46Google Scholar
  200. Swinnen LJ, Constanzo-Nordin MR, Fisher SG et al. (1990) Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 323:1723–1728PubMedGoogle Scholar
  201. Symmons DPM (1985) Neoplasms of the immune system in rheumatoid arthritis. Am J Med 78:22–28PubMedGoogle Scholar
  202. Taillan B, Gamier G, Castanet J, Ferrari E, Pesce A, Dujardin P (1993) Lymphoma development in a patient with rheumatoid arthritis taking methotrexate. Clin Rheumatol 12:93–94PubMedGoogle Scholar
  203. Tao J, Valderrama E (1999) Epstein-Barr virus-associated polymorphic B-cell lymphoproliferative disorders in the lungs of children with AIDS. Report of two cases. Am J Surg Pathol 23:560–566PubMedGoogle Scholar
  204. Tao J, Savargaonkar P, Vallejo C, Cesarman E, Fuchs A (2000) Aggressive natural killer cell lymphoma presenting as a anterior mediastinal mass in a patient with the acquired immunodeficiency syndrome. Arch Pathol Lab Med 124:304–309PubMedGoogle Scholar
  205. Taylor AMR, Metcalfe JA, Thick J, Mak Y-F (1996) Leukemia and lymphoma in ataxia telangiectasia. Blood 87:423–438PubMedGoogle Scholar
  206. Terruya-Feldstein J, Temeck BK, Sloas MM et al. (1995) Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient. Am J Surg Pathol 19:357–363Google Scholar
  207. Thomasen RW, Craig FE, Banks PM (1996) Epstein-Barr virus and lymphoproliferation in methothrexate rheumatoid arthritis. Mod Pathol 9:261–266Google Scholar
  208. Thorley-Lawson DA, Poodry CA (1982) Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo. J Virol 43:730–736PubMedGoogle Scholar
  209. Tinguely M, Vonlanthen R, Muller E et al. (1998) Hodgkin’s disease-like lymphoproliferative disorders in patients with different underlying immunodeficiency states. Mod Pathol 11:307–312PubMedGoogle Scholar
  210. Tirelli U, Errante D, Dolcetti R et al. (1995) Hodgkin’s disease and human immunodeficiency virus infection: clinicopathologic and virologie features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 13:1785–1767Google Scholar
  211. Ventura G, Lucia MB, Damiano F, Cauda R, Larocca LM (1995) Multiple myeloma associated with Epstein-Barr virus in an AIDS-patient: a case report. Eur J Haematol 55:332–334PubMedGoogle Scholar
  212. Villareal LP (1997) On viruses, sex and motherhood. J Virol 71:859–865PubMedGoogle Scholar
  213. Virgilio L, Isobe M, Narducci MG et al. (1993) Chromosome walking on the TCL1 locus involved T-cell neoplasia. Proc Nati Acad Sci USA 90:9275–9279Google Scholar
  214. Walts AE, Shintaku P, Said JW (1990) Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. Am J Clin Pathol 94:170–175PubMedGoogle Scholar
  215. Whitherspoon RP, Fisher LD, Schoch G et al. (1989) Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 321:9–13Google Scholar
  216. Willis TG, Jadayel DM, Du M-Q et al. (1999) BCL10 is involved in (t;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96:35–45PubMedGoogle Scholar
  217. Wilson WH, Kingma DW, Raffeld M, Jaffe ES (1996) Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-α 2b. Blood 87:4531–4537PubMedGoogle Scholar
  218. Wotherspoon AC, Diss TC, Pan L, Singh N, Whelan J, Isaacson PG (1996) Low grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue in immunocompromised patients. Histopathology 28:129–134PubMedGoogle Scholar
  219. Yao QY, Ogan P, Rowe M, Wood M, Rickinson AB (1989) The Epstein-Barr virus: host balance in acute infectious mononucleosis patients receiving acyclovir anti-viral therapy. Int J Cancer 43:61–66PubMedGoogle Scholar
  220. Yates JL, Warren N, Sudgen B (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812–815PubMedGoogle Scholar
  221. Ye BH, Rao PH, Chaganti RS, Dalla-Favera R (1993) Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 53:2732–2735PubMedGoogle Scholar
  222. Young L, Alfieri C, Hennessy K et al. (1989) Expression of Epstein-Barr virus transformation associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080–1085PubMedGoogle Scholar
  223. Ziegler JL, Drew WL, Miner RC (1982) Outbreak of Burkitt’s-like lymphoma in homosexual men. Lancet 2:631–633PubMedGoogle Scholar
  224. Ziegler JL, Beckstead JA, Volberding PA et al. (1984) Non-Hodgkin’s lymphoma in 90 homosexual men. N Engl J Med 311:565–570PubMedGoogle Scholar
  225. Zuckerman E, Zuckerman T, Sahar D et al. (2001) The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 97:1555–1559PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Bettina Borisch
  • Paulette Mhawech
  • Marianne Tinguely

There are no affiliations available

Personalised recommendations